Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Prebiotics-induced anti-tumor immunity attenuates tumor growth

PROVIDER: PRJNA593851 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10594900_1.fastq.gz	Fastqsanger.gz
	SRR10594900_2.fastq.gz	Fastqsanger.gz
	SRR10595000_1.fastq.gz	Fastqsanger.gz
	SRR10595000_2.fastq.gz	Fastqsanger.gz
	SRR10595100_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 952

Similar Datasets

Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages [scRNA-seq]

Project description:Signaling through Notch receptors intrinsically regulates tumor cell development and growth. However, whether Notch ligands on cancer cells impact anti-tumor immunity remains unclear. We demonstrate that deletion of Notch ligand Jagged2, but not Jagged1, in lung cancer cells attenuates tumor growth and activates anti-tumor T cell responses. Jagged2 deletion in cancer cells incites intra-tumor accumulation of macrophages with elevated capacity to uptake, process, and present antigens. Also, transfer of Jagged2KO tumors-related macrophages into mice provokes lymphocyte-mediated anti-tumor actions, while macrophage ablation in mice restores Jagged2KO tumor growth. Jagged2 deletion on lung tumors induces Notch ligands DLL1/4, which signal through Notch1-2 on macrophages to stimulate IRF4-driven anti-tumor responses. Intercepting DLL1/4 in tumors or IRF4 in myeloid cells blunts macrophage expansion and reinstates Jagged2KO tumor growth. Therapeutically, anti-Jagged2 treatments restrict tumor growth and augment immunotherapy effectiveness. Findings elucidate how cancer cell Jagged2 promotes immune-evasion and identify Jagged2-targeting immunotherapy to activate anti-tumor immunity.

2024-04-17 | GSE228105 | GEO

Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages

2024-04-17 | GSE227671 | GEO

Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+ T cells

Project description:Tumors use various strategies for immune evasion. Understanding the mechanisms by which tumors suppress anti-tumor immunity facilitates the development of immunotherapies. Here we have identified tumor-secreted fibroblast growth factor 21 (FGF21) as an essential immune suppressor. We show that FGF21 is upregulated in multiple types of tumors and promotes tumor progression. FGF21 significantly disrupts CD8+T anti-tumor immune response by rewiring cholesterol metabolism of CD8+ T cells. We further reveal that FGF21 activates AKT-mTORC1- sterolregulatoryelementbindingprotein 1 (SREBP1) signal axis to enhance cholesterol biosynthesis in CD8+T cells. FGF21 knockdown or blockade of FGF21 by a neutralizing antibody attenuates AKT-mTORC1 signaling and subsequently decreases cholesterol content in CD8+T cells, thus restoring CD8+T cytotoxic function and robustly suppressing tumor growth. Our findings uncover FGF21 as a “secreted immune checkpoint” to restrict anti-tumor immunity and suggest its inhibition is a useful strategy for improving the efficacy of cancer immunotherapy.

2024-06-29 | GSE236180 | GEO

The accessible genome regions in inducible melanoma tumor cells grown in the presence or absence of T cells

Project description:The goal of this ATAC sequencing design is to identify critical transcription factors in controlling melanoma tumor growth to evade T cell anti-tumor immunity. The melanoma was induced by tamoxifen followed by T cell depletion with anti-CD4/8. The tumor cells were sorted according to EGFP for following ATAC-seq library preparation.

2022-11-15 | GSE190993 | GEO

PRMT1 suppresses anti-tumor immunity

Project description:PRMT1 suppresses anti-tumor immunity

| PRJNA840921 | ENA

Project description:Wolbachia-induced anti-Plasmodium immunity

| PRJNA1073515 | ENA

RNA sensing induced by chromosome missegregation augments anti-tumor immunity VI

Project description:RNA sensing induced by chromosome missegregation augments anti-tumor immunity VI

| PRJNA1183430 | ENA

RNA sensing induced by chromosome missegregation augments anti-tumor immunity III

Project description:RNA sensing induced by chromosome missegregation augments anti-tumor immunity III

| PRJNA1183429 | ENA